基层医生主导的人群前列腺癌筛查项目:弥合泌尿诊疗可及性缺口
本研究评估了基层医疗主导的社区PSA筛查项目的可行性与结局。主要分析队列927人中89.8%符合2023 AUA指南筛查标准,PSA>4 ng/mL者经mpMRI分诊后12例活检确诊9例前列腺癌,48%的高PSA完成检查者避免了泌尿转诊。扩展队列1773人共50例转诊、21例接受根治性治疗。
要点
- 基层主导的PSA筛查项目指南依从性达89.8%,可有效识别有临床意义的前列腺癌。
- PSA>4 ng/mL者经mpMRI分诊,活检确诊前列腺癌比例为75%(9/12)。
- 整合mpMRI分诊可使48%的高PSA完成检查者安全避免泌尿外科转诊。
核心结论
- 基层医疗主导的PSA筛查模型能有效识别有临床意义的前列腺癌,同时保持90%的指南依从性并减少不必要的专科转诊。
- 整合mpMRI分诊的框架为弥合医疗资源不足社区的泌尿诊疗缺口提供了可扩展策略。
研究设计与样本
- 回顾性分析两个队列:主要分析队列n=927(2022年6月至2023年8月),评估指南依从性与临床结局。
- 扩展项目队列n=1773(截至2024年12月),评估项目可扩展性。
主要发现
- 主要队列中833例(89.8%)筛查符合指南,94例(10.2%)不符合指南者均未转诊泌尿外科。
- 符合指南且PSA>4 ng/mL者共71例,其中49例接受mpMRI,23例(47%)显示PI-RADS 3-5病变。
- 12例接受活检,确诊前列腺癌9例(75%)。
- 26例(占高PSA且完成检查者的48%)通过MRI阴性或重复PSA正常安全避免泌尿转诊。
- 扩展队列1773人中,项目共产生50例泌尿转诊和21例接受根治性治疗。
关键数值与推荐
- 依据2023 AUA指南,45-69岁男性或40-44岁具有高危特征(黑人血统或家族史)者筛查为「合适」。
- PSA>4 ng/mL者接受重复检测和/或mpMRI分诊。
临床怎么用
- 在基层医疗中按2023 AUA指南开展PSA筛查,对PSA>4 ng/mL者采用重复检测和/或mpMRI分诊。
- 利用mpMRI分诊可减少不必要的泌尿外科转诊,同时不遗漏有临床意义的前列腺癌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility and outcomes of a primary care-led, community-based prostate-specific antigen (PSA) screening program designed to improve access to diagnosis in underserved populations. METHODS: We retrospectively analyzed two cohorts: a Primary Analysis Cohort (n = 927; 6/2022-8/2023) to assess guideline adherence and clinical outcomes, and an Extended Programmatic Cohort (n = 1773; through 12/2024) to evaluate program scalability. Per 2023 AUA guidelines, screening was "appropriate" for men aged 45-69, or aged 40-44 with high-risk features (Black ancestry or family history). Patients with PSA >4ng/mL underwent repeat testing and/or mpMRI triage. RESULTS: In the primary cohort, 833 (89.8%) participants were screened appropriately. Of the 94 (10.2%) screened outside guidelines, none were referred to urology. Among appropriately screened men with PSA >4 ng/mL (n = 71), 49 underwent mpMRI, with 23 (47%) demonstrating PI-RADS 3-5 findings. Twelve patients underwent biopsy, yielding nine (75%) prostate cancer diagnoses. Notably, 26 patients (48% of those with elevated PSA and completed work-ups) safely avoided urology referral through negative MRI findings or normalized repeat PSA results. In the extended cohort (n = 1773), the program resulted in 50 total urology referrals and 21 patients receiving definitive treatment. CONCLUSION: This primary care-driven model effectively identifies clinically significant prostate cancer while maintaining high (90%) guideline adherence and reducing unnecessary specialist referrals. By integrating mpMRI triage, this framework provides a scalable strategy to bridge urologic care gaps and mitigate health disparities in underserved communities.
引用
- Ashbrook CQ, Troia TC, Woldu SL, et al. Primary Care Physician-led Population-based Screening Program for Prostate Cancer: Bridging a Urologic Gap in Access to Care. Urology. 2026. PMID: 41937034. doi:10.1016/j.urology.2026.04.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。